A citation-based method for searching scientific literature

Emma J Crosbie, Nicola Flaum, Elaine F Harkness, Richard D Clayton, Cathrine Holland, Pierre Martin-Hirsch, Nick Wood, Patrick Keating, Emma R Woodward, Fiona Lalloo, Paul Donnai, Richard J Edmondson, D Gareth Evans. Int J Cancer 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
100


Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.
Marline G Harmsen, Jurgen M J Piek, Johan Bulten, Murray J Casey, Timothy R Rebbeck, Marian J Mourits, Mark H Greene, Brigitte F M Slangen, Marc van Beurden, Leon F A G Massuger,[...]. Cancer 2018
14
100

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
100


Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Murray Joseph Casey, Carrie Synder, Chhanda Bewtra, Steven A Narod, Patrice Watson, Henry T Lynch. Gynecol Oncol 2005
56
100

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
119
100

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Douglas A Levine, Peter A Argenta, Cindy J Yee, David S Marshall, Narciso Olvera, Faina Bogomolniy, Jamal A Rahaman, Mark E Robson, Kenneth Offit, Richard R Barakat,[...]. J Clin Oncol 2003
120
100

Serous carcinogenesis in the fallopian tube: a descriptive classification.
Elke Jarboe, Ann Folkins, Marisa R Nucci, David Kindelberger, Ronny Drapkin, Alexander Miron, Yonghee Lee, Christopher P Crum. Int J Gynecol Pathol 2008
195
100

p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Karoline Leonhardt, Jens Einenkel, Sindy Sohr, Kurt Engeland, Lars-Christian Horn. Int J Gynecol Pathol 2011
37
100


Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.
Sarah L Ingham, Matthew Sperrin, Andrew Baildam, Gary L Ross, Richard Clayton, Fiona Lalloo, Iain Buchan, Anthony Howell, D Gareth R Evans. Breast Cancer Res Treat 2013
33
100

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
394
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
100

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
211
100

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Denise R Nebgen, Jean Hurteau, Laura L Holman, Andrea Bradford, Mark F Munsell, Beth R Soletsky, Charlotte C Sun, Gary B Chisholm, Karen H Lu. Gynecol Oncol 2018
31
100

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
D G Evans, K N Gaarenstroom, D Stirling, A Shenton, L Maehle, A Dørum, M Steel, F Lalloo, J Apold, M E Porteous,[...]. J Med Genet 2009
82
100

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
100

Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy.
Christos Iavazzo, Ioannis D Gkegkes, Nikolaos Vrachnis. J Turk Ger Gynecol Assoc 2016
12
100

Ovarian cancer family and prophylactic choices.
D G Evans, G Ribiero, D Warrell, D Donnai. J Med Genet 1992
20
100

A systematic review and meta-analysis of family history and risk of ovarian cancer.
J F Stratton, P Pharoah, S K Smith, D Easton, B A Ponder. Br J Obstet Gynaecol 1998
145
100

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
Honglin Song, Mine S Cicek, Ed Dicks, Patricia Harrington, Susan J Ramus, Julie M Cunningham, Brooke L Fridley, Jonathan P Tyrer, Jennifer Alsop, Mercedes Jimenez-Linan,[...]. Hum Mol Genet 2014
76
100

The role of the fallopian tube in ovarian cancer.
Alicia A Tone, Shannon Salvador, Sarah J Finlayson, Anna V Tinker, Janice S Kwon, Cheng-Han Lee, Trevor Cohen, Tom Ehlen, Marette Lee, Mark S Carey,[...]. Clin Adv Hematol Oncol 2012
67
100

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Christian F Singer, Pal Moller, Henry T Lynch, Susan Armel, Beth Karlan, William D Foulkes, Susan L Neuhausen,[...]. J Natl Cancer Inst 2016
133
100

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families.
J K Tobacman, M H Greene, M A Tucker, J Costa, R Kase, J F Fraumeni. Lancet 1982
297
100

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017
81
100

The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian Cancer.
Bradley J Monk, Leslie M Randall, Rachel N Grisham. Am Soc Clin Oncol Educ Book 2019
8
100

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Diane Stirling, D Gareth R Evans, Gabriella Pichert, Andrew Shenton, Elaine N Kirk, Sylvia Rimmer, C Michael Steel, Sheila Lawson, R M Camille Busby-Earle, Jane Walker,[...]. J Clin Oncol 2005
110
100

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
P I Stanciu, T E J Ind, D P J Barton, J B Butler, K M Vroobel, A D Attygalle, M A E Nobbenhuis. J Ovarian Res 2019
6
100

Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.
D Gareth R Evans, Richard Clayton, Paul Donnai, Andrew Shenton, Fiona Lalloo. Eur J Hum Genet 2009
24
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.